Skip to content

Effect of para-cognition therapy on depression

Comparative study of effect of Citalopram and Para-cognition therapy on severity of depression in major depressive disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201602012266N5
Enrollment
45
Registered
2016-04-11
Start date
2014-07-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depression.

Interventions

Intervention 1: intervention groups-I: para-cognitive therapy performs on the first intervention group during ten 1-hour sessions (a new method of psychotherapy that is mostly concerned with the eff
Behavior
Treatment - Drugs
intervention groups-I: para-cognitive therapy performs on the first intervention group during ten 1-hour sessions (a new method of psychotherapy that is mostly concerned with the effect of depressio
Intervention groups-II: 10-60 mg citalopram ( a standard and widely used antidepressant from SSRI group of antidepressants) will be administer in a daily single dose, the drug will be started 10 mg/
Control group: do not receive any interventions and they will be place on waiting list.

Sponsors

Isfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: age 18-60 years; mild-moderate depression; no psychotic symptoms; no history of mania and hypo-mania; no other axis-I Disorders; completing of consent form Exclusion criteria: Desire to exit from study; increasing the severity of depression and needing to complementary treatments; including to any other treatment modality during study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of depression. Timepoint: before and after of intervention. Method of measurement: Quwstionair.

Secondary

MeasureTime frame
Cognitive emotion regulation. Timepoint: before and after the intervention. Method of measurement: Questionair.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Gholam Reza kheirabadi

Isfahan University of Medical Sciences

kheirabadi@bsrc.mui.ac.ir+98 31 3222 2135

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026